Timothy P L Roberts1, Luke Bloy1, Judith S Miller2, Lisa Blaskey1,2, Judith Ross3,4. 1. Department of Radiology, Lurie Family Foundations MEG Imaging Center. 2. Department of Pediatrics, Center for Autism Research, Children's Hospital of Philadelphia. 3. Department of Pediatrics, Thomas Jefferson University, Philadelphia, Pennsylvania. 4. Department of Pediatrics, Nemours DuPont Hospital for Children, Wilmington, Delaware, USA.
Abstract
BACKGROUND: 47,XYY syndrome (XYY) is a male sex chromosome disorder where subjects have one X chromosome and two copies of the Y chromosome. XYY is associated with a physical phenotype and carries increased risk of neurodevelopmental disorders such as autism spectrum disorder (ASD). Imbalance of excitation and inhibition has been proposed as a putative biological basis of disorders such as ASD [1-3] and several studies have reported atypical brain γ-aminobutyric acid (GABA) levels in this population. Given the male preponderance in the prevalence of ASD, the unique presence of the Y chromosome in males leads to the intriguing possibility of investigating boys with XYY syndrome as a model of excess Y-chromosome genes. METHOD: In this study, we investigated the associations of genotype and clinical phenotype with levels of GABA, estimated by regionally localized edited magnetic resonance spectroscopy in boys with 47, XYY syndrome compared to age-matched typically developing (XY) peers. RESULTS: Overall, we observed a decrease in GABA levels in XYY vs. XY, which appeared more significant in the left compared to the right hemisphere. There was no additional significant modulation of GABA levels in XYY according to presence/absence of ASD diagnosis. Interestingly, a positive correlation between bilateral GABA levels and testosterone levels was observed in pubescent XY boys that was not observed in XYY. CONCLUSION: The inhibitory neurotransmitter GABA appears to be reduced in boys with 47,XYY, especially in the left hemisphere. Further, the typical association between GABA and testosterone levels, observed in older typically developing control boys was not evident in boys with 47,XYY.
BACKGROUND: 47,XYY syndrome (XYY) is a male sex chromosome disorder where subjects have one X chromosome and two copies of the Y chromosome. XYY is associated with a physical phenotype and carries increased risk of neurodevelopmental disorders such as autism spectrum disorder (ASD). Imbalance of excitation and inhibition has been proposed as a putative biological basis of disorders such as ASD [1-3] and several studies have reported atypical brain γ-aminobutyric acid (GABA) levels in this population. Given the male preponderance in the prevalence of ASD, the unique presence of the Y chromosome in males leads to the intriguing possibility of investigating boys with XYY syndrome as a model of excess Y-chromosome genes. METHOD: In this study, we investigated the associations of genotype and clinical phenotype with levels of GABA, estimated by regionally localized edited magnetic resonance spectroscopy in boys with 47, XYY syndrome compared to age-matched typically developing (XY) peers. RESULTS: Overall, we observed a decrease in GABA levels in XYY vs. XY, which appeared more significant in the left compared to the right hemisphere. There was no additional significant modulation of GABA levels in XYY according to presence/absence of ASD diagnosis. Interestingly, a positive correlation between bilateral GABA levels and testosterone levels was observed in pubescent XY boys that was not observed in XYY. CONCLUSION: The inhibitory neurotransmitter GABA appears to be reduced in boys with 47,XYY, especially in the left hemisphere. Further, the typical association between GABA and testosterone levels, observed in older typically developing control boys was not evident in boys with 47,XYY.
Authors: Luke Bloy; Matthew Ku; J Christopher Edgar; Judith S Miller; Lisa Blaskey; Judith Ross; Timothy P L Roberts Journal: Neuroreport Date: 2019-05-01 Impact factor: 1.837
Authors: Nicole R Tartaglia; Rebecca Wilson; Judith S Miller; Jessica Rafalko; Lisa Cordeiro; Shanlee Davis; David Hessl; Judith Ross Journal: J Dev Behav Pediatr Date: 2017-04 Impact factor: 2.225
Authors: Dorothy V M Bishop; Patricia A Jacobs; Katherine Lachlan; Diana Wellesley; Angela Barnicoat; Patricia A Boyd; Alan Fryer; Prisca Middlemiss; Sarah Smithson; Kay Metcalfe; Deborah Shears; Victoria Leggett; Kate Nation; Gaia Scerif Journal: Arch Dis Child Date: 2010-07-23 Impact factor: 3.791
Authors: John N Constantino; Sandra A Davis; Richard D Todd; Matthew K Schindler; Maggie M Gross; Susan L Brophy; Lisa M Metzger; Christiana S Shoushtari; Reagan Splinter; Wendy Reich Journal: J Autism Dev Disord Date: 2003-08
Authors: Shanlee M Davis; Luke Bloy; Timothy P L Roberts; Karen Kowal; Amanda Alston; Aysha Tahsin; Alyssa Truxon; Judith L Ross Journal: Am J Med Genet C Semin Med Genet Date: 2020-06-16 Impact factor: 3.908